This study is a big deal. Is it going to be the one that kicks down the PRS door? Maybe. And that’s saying something.
Assessment of a Polygenic Risk Score in Screening for Prostate Cancer https://www.nejm.org/doi/full/10.1056/NEJMoa2407934
Assessment of a Polygenic Risk Score in Screening for Prostate Cancer https://www.nejm.org/doi/full/10.1056/NEJMoa2407934
Comments
Ros Eeles may indeed be right that a PRS to augment prostate cancer screening could turn the tide. These data could also be used to improve detection/prevention of many more diseases. Its a long road for clinical implementation but looks worth it.
Link 1: https://www.ox.ac.uk/news/2023-03-13-study-shows-delaying-treatment-localised-prostate-cancer-does-not-increase-mortality
Link 2: https://medicine.washu.edu/news/surgery-early-prostate-cancer-may-not-save-lives/